- Home
- DWSN vs ESLA Comparison
DWSN vs ESLA Comparison
Compare DWSN & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DWSN
- ESLA
- Stock Information
- Founded
- DWSN 1952
- ESLA 2021
- Country
- DWSN United States
- ESLA United States
- Employees
- DWSN N/A
- ESLA N/A
- Industry
- DWSN Oil & Gas Production
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DWSN Energy
- ESLA Health Care
- Exchange
- DWSN Nasdaq
- ESLA Nasdaq
- Market Cap
- DWSN 58.4M
- ESLA 48.9M
- IPO Year
- DWSN N/A
- ESLA N/A
- Fundamental
- Price
- DWSN $2.20
- ESLA $2.28
- Analyst Decision
- DWSN
- ESLA Strong Buy
- Analyst Count
- DWSN 0
- ESLA 1
- Target Price
- DWSN N/A
- ESLA $16.00
- AVG Volume (30 Days)
- DWSN 77.6K
- ESLA 372.9K
- Earning Date
- DWSN 11-11-2025
- ESLA 11-20-2025
- Dividend Yield
- DWSN N/A
- ESLA N/A
- EPS Growth
- DWSN N/A
- ESLA N/A
- EPS
- DWSN N/A
- ESLA N/A
- Revenue
- DWSN $55,987,000.00
- ESLA N/A
- Revenue This Year
- DWSN N/A
- ESLA N/A
- Revenue Next Year
- DWSN N/A
- ESLA N/A
- P/E Ratio
- DWSN N/A
- ESLA N/A
- Revenue Growth
- DWSN N/A
- ESLA N/A
- 52 Week Low
- DWSN $1.08
- ESLA $0.63
- 52 Week High
- DWSN $5.54
- ESLA $2.55
- Technical
- Relative Strength Index (RSI)
- DWSN 63.49
- ESLA 72.65
- Support Level
- DWSN $1.76
- ESLA $2.02
- Resistance Level
- DWSN $1.90
- ESLA $2.55
- Average True Range (ATR)
- DWSN 0.17
- ESLA 0.28
- MACD
- DWSN 0.03
- ESLA 0.08
- Stochastic Oscillator
- DWSN 77.92
- ESLA 80.00
About DWSN Dawson Geophysical Company
Dawson Geophysical Co is a provider of onshore seismic data acquisition services with operations throughout the continental United States and Canada. The company acquires and processes 2 D, 3 D, and multi-component seismic data for clients, ranging from oil and gas companies to independent oil and gas operators for use in the onshore drilling and production of oil and natural gas as well as provides multi-client data libraries. It operates through a single segment being Contract seismic data acquisition and processing services. In addition, the company provides multi-component seismic data surveys which involve the recording of alternative seismic waves. Geographically, it generates maximum revenue from the United States.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.